advertisement
Chen M 72
Showing records 1 to 25 | Display all abstracts from Chen M120268 Green-Light-Triggered and Self-Calibrated Cascade Release of Nitric Oxide and Carbon Monoxide for Synergistic Glaucoma Therapy
Chen X
Journal of the American Chemical Society 2024; 146: 30361-30371
123064 Establishment of a CPAMD8-GFP reporter human embryonic stem cell line, IBBDe001-B, using CRISPR/Cas9 editing
Zhang S
Stem cell research 2024; 81: 103615
121696 NADPH and NAC synergistically inhibits chronic ocular hypertension-induced neurodegeneration and neuroinflammation through regulating p38/MAPK pathway and peroxidation
Yu N
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 175: 116711
124172 The spike of acute angle closure after the epidemic downgrade of COVID-19 management: a hospital-based comparative study from China
Zhang Q
International Ophthalmology 2024; 44: 299
120277 Mendelian randomization supports causality between COVID-19 and glaucoma
Chen M
Medicine 2024; 103: e38455
124492 Effect of intraocular pressure reduction on progressive high myopia (PHM study): study protocol of a randomised controlled trial
Jiang J
BMJ open 2024; 14: e084068
121696 NADPH and NAC synergistically inhibits chronic ocular hypertension-induced neurodegeneration and neuroinflammation through regulating p38/MAPK pathway and peroxidation
Yu N
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 175: 116711
124800 Antibiotic tolerance due to restriction of cAMP-Crp regulation by mannitol, a non-glucose-family PTS carbon source
Zhu W
mSphere 2024; 9: e0077224
120277 Mendelian randomization supports causality between COVID-19 and glaucoma
Zhang Y
Medicine 2024; 103: e38455
124800 Antibiotic tolerance due to restriction of cAMP-Crp regulation by mannitol, a non-glucose-family PTS carbon source
Chen M
mSphere 2024; 9: e0077224
120268 Green-Light-Triggered and Self-Calibrated Cascade Release of Nitric Oxide and Carbon Monoxide for Synergistic Glaucoma Therapy
Liu J
Journal of the American Chemical Society 2024; 146: 30361-30371
124492 Effect of intraocular pressure reduction on progressive high myopia (PHM study): study protocol of a randomised controlled trial
Lin T
BMJ open 2024; 14: e084068
121696 NADPH and NAC synergistically inhibits chronic ocular hypertension-induced neurodegeneration and neuroinflammation through regulating p38/MAPK pathway and peroxidation
Wu X
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 175: 116711
124172 The spike of acute angle closure after the epidemic downgrade of COVID-19 management: a hospital-based comparative study from China
Ye Z
International Ophthalmology 2024; 44: 299
123064 Establishment of a CPAMD8-GFP reporter human embryonic stem cell line, IBBDe001-B, using CRISPR/Cas9 editing
Li J; Pan W
Stem cell research 2024; 81: 103615
124172 The spike of acute angle closure after the epidemic downgrade of COVID-19 management: a hospital-based comparative study from China
Cheng B
International Ophthalmology 2024; 44: 299
120277 Mendelian randomization supports causality between COVID-19 and glaucoma
Yao Y
Medicine 2024; 103: e38455
120268 Green-Light-Triggered and Self-Calibrated Cascade Release of Nitric Oxide and Carbon Monoxide for Synergistic Glaucoma Therapy
Chen M
Journal of the American Chemical Society 2024; 146: 30361-30371
124800 Antibiotic tolerance due to restriction of cAMP-Crp regulation by mannitol, a non-glucose-family PTS carbon source
Zhang X
mSphere 2024; 9: e0077224
121696 NADPH and NAC synergistically inhibits chronic ocular hypertension-induced neurodegeneration and neuroinflammation through regulating p38/MAPK pathway and peroxidation
Zhang C
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 175: 116711
124492 Effect of intraocular pressure reduction on progressive high myopia (PHM study): study protocol of a randomised controlled trial
Lin F
BMJ open 2024; 14: e084068
120277 Mendelian randomization supports causality between COVID-19 and glaucoma
Huang Y
Medicine 2024; 103: e38455
121696 NADPH and NAC synergistically inhibits chronic ocular hypertension-induced neurodegeneration and neuroinflammation through regulating p38/MAPK pathway and peroxidation
Qin Q
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 175: 116711
124492 Effect of intraocular pressure reduction on progressive high myopia (PHM study): study protocol of a randomised controlled trial
Kong K
BMJ open 2024; 14: e084068
123064 Establishment of a CPAMD8-GFP reporter human embryonic stem cell line, IBBDe001-B, using CRISPR/Cas9 editing
Ren Q
Stem cell research 2024; 81: 103615
